fk 1052 has been researched along with 2-methyl-5-ht in 1 studies
| Studies (fk 1052) | Trials (fk 1052) | Recent Studies (post-2010) (fk 1052) | Studies (2-methyl-5-ht) | Trials (2-methyl-5-ht) | Recent Studies (post-2010) (2-methyl-5-ht) |
|---|---|---|---|---|---|
| 12 | 0 | 2 | 219 | 0 | 15 |
| Protein | Taxonomy | fk 1052 (IC50) | 2-methyl-5-ht (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 3A | Rattus norvegicus (Norway rat) | 0.779 | |
| 5-hydroxytryptamine receptor 3B | Rattus norvegicus (Norway rat) | 0.779 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kadowaki, M; Kohsaka, M; Mori, J; Nagakura, Y; Tokoro, K; Tomoi, M | 1 |
1 other study(ies) available for fk 1052 and 2-methyl-5-ht
| Article | Year |
|---|---|
Pharmacological characterization of FK1052, a dihydropyridoindole derivative, as a new serotonin 3 and 4 dual receptor antagonist.
Topics: 5-Methoxytryptamine; Acetylcholine; Animals; Bradycardia; Electric Stimulation; Guinea Pigs; Histamine; Ileum; Imidazoles; In Vitro Techniques; Indoles; Male; Molecular Structure; Muscle Contraction; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists | 1993 |